Therapeutics and Clinical Risk Management: 2023, vol: 19, issue:
1)- Jennifer Gallardo-Cóndor, Pablo Naranjo, Sebastián Atarihuana, Dayana Coello, Patricia Guevara-Ramírez, Rodrigo Flores-Espinoza, Germán Burgos, Andrés López-Cortés, Alejandro Cabrera-Andrade. Population-Specific Distribution of Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine.Therapeutics and clinical risk management. 2023, 19: 1005-1018
2)- Samuel Frank, Aljoharah Alakkas. Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia.Therapeutics and clinical risk management. 2023, 19: 1019-1024
3)- Chutipong Kwantong, Yuda Sutherasan, Detajin Junhasavasdikul, Tananchai Petnak, Pongdhep Theerawit. Effect of the Ramathibodi Rapid Response System Triggered by the Ramathibodi Early Warning Score and Clinical Warning Signs on in-Hospital Mortality and the Incidence of Cardiopulmonary Resuscitation in Adult Hospitalized Patients.Therapeutics and clinical risk management. 2023, 19: 1025-1038
4)- Han Qi, Zhitao Zhu, Dongsheng Zhu. Erythrocyte Sedimentation Rate for Assisted Diagnosis of Pediatric Osteomyelitis: A Meta-Analysis.Therapeutics and clinical risk management. 2023, 19: 1039-1049
6)- María A Rodríguez-Scarpetta, Andrés M Sepúlveda-Tobón, Jorge E Daza-Arana, Heiler Lozada-Ramos, Rodrigo A Álzate-Sánchez. Central Oxygen Venous Saturation and Mortality in Patients Undergoing Coronary Artery Bypass Grafting.Therapeutics and clinical risk management. 2023, 19: 447-454
7)- Ping-Chen Hou, Nathalie Del Agua, Su M Lwin, Chao-Kai Hsu, John A McGrath. Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects.Therapeutics and clinical risk management. 2023, 19: 455-473
9)- Bo Cong, Tao Sun, Yuchi Zhao, Mingqi Chen. Current and Novel Therapeutics for Articular Cartilage Repair and Regeneration.Therapeutics and clinical risk management. 2023, 19: 485-502
10)- Hanqing Liu, Man Lu, Jiawei Hu, Guangzhao Fu, Qinyu Feng, Shengrong Sun, Chuang Chen. Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.Therapeutics and clinical risk management. 2023, 19: 503-523
12)- Dahniel Sastow, Douglas Tremblay. Emerging Treatment Options for Myelofibrosis: Focus on Anemia.Therapeutics and clinical risk management. 2023, 19: 535-547
13)- Na Zhao, Bowen Sun, Yuan Cheng, Jianliu Wang. Heterogeneity of CD40 Expression in Different Types of High-Risk Endometrial Cancer Affects Discordant Prognostic Outcomes.Therapeutics and clinical risk management. 2023, 19: 549-556
14)- Hui Xu, Shuhui Hou, Zhengyi Ruan, Jianhua Liu. Comparing Anatomical and Functional Outcomes of Two Neovaginoplasty Techniques for Mayer-Rokitansky-Küster-Hauser Syndrome: A Ten-Year Retrospective Study with Swine Small Intestinal Submucosa and Homologous Skin Grafts.Therapeutics and clinical risk management. 2023, 19: 557-565
15)- Patricia López-Chicón, Maria Luisa Pérez, Cristina Castells-Sala, Ana Rita Piteira, Oscar Fariñas, Jaime Tabera, Anna Vilarrodona. Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII Methodologies.Therapeutics and clinical risk management. 2023, 19: 567-578
16)- Theo Moraes Teixeira, Luis Filipe de Souza Godoy, Wellingson Silva Paiva. Diffusion Tensor Imaging for Evaluating Postoperative Outcomes of Supratentorial Glioma in the Motor Function Area [Letter].Therapeutics and clinical risk management. 2023, 19: 579-580
17)- Wenbing Zhang, Jian Ding, Wenhai Wang, Duo Wang, Yinping Pan, Dexin Xu. Status and Future Directions of Therapeutics and Prognosis of Cardiac Amyloidosis.Therapeutics and clinical risk management. 2023, 19: 581-597
19)- Maria Komariah, Shakira Amirah, Sidik Maulana, Muhammad Fahd Abdurrahman, Kusman Ibrahim, Hesti Platini, Juan Alessandro Jeremis Maruli Nura Lele, Kelvin Kohar, Laili Rahayuwati, Mohd Khairul Zul Hasymi Firdaus. The Efficacy of Herbs as Complementary and Alternative Therapy in Recovery and Clinical Outcome Among People with COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression.Therapeutics and clinical risk management. 2023, 19: 611-627
20)- Syah Mirsya Warli, Steven Steven, Dhirajaya Dharma Kadar, Fauriski Febrian Prapiska, Ginanda Putra Siregar. The Efficacy and Safety of Avanafil During a Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Therapeutics and clinical risk management. 2023, 19: 629-644
21)- Felice Alfonso Nava, Alessandra Mangia, Marco Riglietta, Lorenzo Somaini, Francesco Giuseppe Foschi, Ernesto Claar, Ivana Maida, Claudio Ucciferri, Francesca Frigerio, Candido Hernandez, Melania Dovizio, Valentina Perrone, Luca Degli Esposti, Massimo Puoti. Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis.Therapeutics and clinical risk management. 2023, 19: 645-656
23)- Örs Péter Horváth, Szabolcs Bellyei, Éva Pozsgai, András Vereczkei. Changes in Oncological Surgical Principles Driven by Advances in Preoperative Treatments.Therapeutics and clinical risk management. 2023, 19: 667-674
24)- Hang Qian, Xu Wang, Pengbo Wang, Guangyang Zhang, Jun Liu, Xiaoqian Dang, Jianbin Guo, Ruiyu Liu. Changes in Anxiety and Depression After THA in Patients with Ankylosing Spondylitis and the Affecting Factors.Therapeutics and clinical risk management. 2023, 19: 675-684
27)- Léa El Haddad, Mainur Khan, Rania Soufny, David Mummy, Bastiaan Driehuys, Wissam Mansour, Priya S Kishnani, Mai K ElMallah. Monitoring and Management of Respiratory Function in Pompe Disease: Current Perspectives.Therapeutics and clinical risk management. 2023, 19: 713-729
29)- Heather D Anderson, Vanessa Paul Patterson, Garth Wright, Julia E Rawlings, Gina D Moore, Jim Leonard, Robert L Page Ii. Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis.Therapeutics and clinical risk management. 2023, 19: 745-753
31)- Xi-Qing Pan, Jin-Hui Liu, Jiang-Li Zhang, An Chai, Feng Li, Lei Shu, Wei Zhao. How to Choose the Appropriate Posterior Slope Angle Can Lead to Good Knee Joint Function Recovery in Total Knee Arthroplasty?Therapeutics and clinical risk management. 2023, 19: 767-772
32)- Yin-Gang Wu, Bowen Wang, Hao Cui, Hao Zhu, Ge Gao. Application of the Willis Covered Stent in the Treatment of Complex Vascular Diseases of the Internal Carotid Artery and Vertebral Artery: A Retrospective Single-Center Experience.Therapeutics and clinical risk management. 2023, 19: 773-782
33)- Yi Chen, Yongli Gao. Comparison of Balanced Crystalloids versus Normal Saline in Critically Ill Patients: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.Therapeutics and clinical risk management. 2023, 19: 783-799
34)- Yanmei Luo, Jie Liu, Zhihui Jiang, Xinghai Yang, Song Lin, Xiaowen Mao. A Multi-Centric Comparative Study Between Endoscopy-Assisted Laparoscopic Surgery (EALS) vs Laparoscopic Surgery for the Treatment of Gastric Duplication Cysts in Children.Therapeutics and clinical risk management. 2023, 19: 801-810
35)- Zhenni Zhao, Jiawei Li, Jiamin Wen, Yanyan He, Zhiling Sun. Effect of Moxibustion on Inflammatory Cytokines for Low Back Pain: A Systematic Review, Meta-Analysis and Meta-Regression.Therapeutics and clinical risk management. 2023, 19: 811-827
36)- Li Luo, Jiduan Jiang, Min Zhang, Zhiqiang Guo, Xianzheng Zhang, Fenglin Wang, Fan Yang. Comparative Study About Different Doses of Remimazolam in Short Laparoscopic Surgery: A Randomized Controlled Double-Blind Trial.Therapeutics and clinical risk management. 2023, 19: 829-837
37)- Aldo Torre, Jacqueline Córdova-Gallardo, Alberto C Frati Munari. Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier.Therapeutics and clinical risk management. 2023, 19: 839-851
38)- Yongkang Xu, Shumin Fu, Kan Liu, Ye Mao, Jianbing Wu. Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study.Therapeutics and clinical risk management. 2023, 19: 853-863
39)- Song Lyu, Guobin Wu, Yingfen Wu. Impact of Prone Jackknife Position on Intraoperative Hypotension During Percutaneous Nephroscopy: A Retrospective Matched Analysis.Therapeutics and clinical risk management. 2023, 19: 865-873
40)- Yu Li, Zhi-Peng Yan, Nan-Nan Zhang, Jun Ni, Zhi-Yong Wang. Investigation into the Effectiveness of Combining Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation as Treatment Options for Poststroke Shoulder Pain by Utilizing Functional Near-Infrared Spectroscopy.Therapeutics and clinical risk management. 2023, 19: 875-887
41)- Daniel Legese Achalu, Foziya Getachew Mohammed, Mekonnen Teferi. Magnitude and Impacts of Adverse Events of Injectable Containing Shorter Regimen in Programmatic Management of Multi-Drug Resistant Tuberculosis in Ethiopia: A Retrospective Cohort Study.Therapeutics and clinical risk management. 2023, 19: 889-901
42)- Alexandra Arias-Mendoza, Jorge A Ortega-Hernández, Diego Araiza-Garaygordobil, Héctor González-Pacheco, Mireya Martínez-García, Enrique Hernández-Lemus, Rodrigo Gopar-Nieto, Tomás Tadeo Sandoval-Aguilar, Daniel Sierra-Lara Martinez, Salvador Mendoza-García, Alfredo Altamirano-Castillo, José Luis Briseño-de-la-Cruz, Midori Alondra Ortega-Hernández, Luis Alejandro Soliz-Uriona, Jorge Gaspar-Hernández. Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits.Therapeutics and clinical risk management. 2023, 19: 903-911
43)- Ahmad Al-Azayzih, Roaa J Kanaan, Shoroq M Altawalbeh. Assessment of Drug-Related Problems and Health-Related Quality of Life Domains in Elderly Patients with Type 2 Diabetes Mellitus.Therapeutics and clinical risk management. 2023, 19: 913-928
44)- Yan Zhang, Wenjun Meng, Chengwen Hu, Meirong Dong, Youqun Chu, Fang Kang, Juan Li, Xia Chen. Effect of Oral Care Solution on Sore Throat After I-Gel Laryngeal Mask General Anesthesia: A Randomized Controlled Trial.Therapeutics and clinical risk management. 2023, 19: 929-936
45)- Nicholas Mielke, Yuying Xing, Steven Matthew Gibson, Emily DiLoreto, Amit Bahl. Bridging the Gap in Traditional PIVC Placement: An Evaluation of Operation STICK Vascular Access Outcomes.Therapeutics and clinical risk management. 2023, 19: 937-948
46)- Ahmed Khalil, Asmaa Mohamed, Manasik Hassan, Samar Magboul, Hossamaldein Ali, Ahmed Salah Elmasoudi, Khaled Ellithy, Mohammad Qusad, Abdulla Alhothi, Eman Al Maslamani, Mohammed Al Amri, Ashraf Soliman. Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study.Therapeutics and clinical risk management. 2023, 19: 949-958
48)- Stacy Dixon, Xuan Kang, Dianna Quan. Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis.Therapeutics and clinical risk management. 2023, 19: 973-981
49)- Xiaorong Xu, Jing Cheng, Yeping Zhang, Xin Wang, Mulei Chen, Lin Xu, Wenshu Zhao. Effectiveness of Heart Failure Checklist Management in Patients with Chronic Heart Failure: An Open-Label, Single-Center Controlled Study During 18 Months of Follow-Up.Therapeutics and clinical risk management. 2023, 19: 983-992